Fractyl Health, Inc. Common Stock (GUTS) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.47
• Market Cap: $77.61M
• EPS: $-2.32
• 52-Week High: $3.03
• 52-Week Low: $0.38

Market Sentiment

Fractyl Health, Inc. Common Stock currently has a Neutral sentiment score of 0.07.

About Fractyl Health, Inc. Common Stock

Fractyl Health, Inc. (GUTS) is a pioneering metabolic therapeutics company headquartered in Lexington, Massachusetts, dedicated to transforming the management of type 2 diabetes (T2D) and obesity. By harnessing advanced research and R&D capabilities, Fractyl is developing innovative therapies that address the underlying mechanisms of these prevalent conditions, aiming to improve long-term patient outcomes. The company's commitment to tackling the root causes of metabolic diseases positions it...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Fractyl Health, Inc. Common Stock and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does GUTS pay dividends?

Fractyl Health, Inc. Common Stock (GUTS) does not currently pay a regular dividend.

What is GUTS's market cap?

Fractyl Health, Inc. Common Stock (GUTS) has a market capitalization of $77.61M with a current stock price of $0.47.